Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, USA.
Nat Commun. 2023 Oct 2;14(1):6147. doi: 10.1038/s41467-023-41819-0.
Polygenic risk scores (PRS) have great potential to guide precision colorectal cancer (CRC) prevention by identifying those at higher risk to undertake targeted screening. However, current PRS using European ancestry data have sub-optimal performance in non-European ancestry populations, limiting their utility among these populations. Towards addressing this deficiency, we expand PRS development for CRC by incorporating Asian ancestry data (21,731 cases; 47,444 controls) into European ancestry training datasets (78,473 cases; 107,143 controls). The AUC estimates (95% CI) of PRS are 0.63(0.62-0.64), 0.59(0.57-0.61), 0.62(0.60-0.63), and 0.65(0.63-0.66) in independent datasets including 1681-3651 cases and 8696-115,105 controls of Asian, Black/African American, Latinx/Hispanic, and non-Hispanic White, respectively. They are significantly better than the European-centric PRS in all four major US racial and ethnic groups (p-values < 0.05). Further inclusion of non-European ancestry populations, especially Black/African American and Latinx/Hispanic, is needed to improve the risk prediction and enhance equity in applying PRS in clinical practice.
多基因风险评分(PRS)具有通过识别高风险人群来进行靶向筛查,从而指导精准结直肠癌(CRC)预防的巨大潜力。然而,目前使用欧洲血统数据的 PRS 在非欧洲血统人群中的表现并不理想,限制了它们在这些人群中的应用。为了解决这一不足,我们通过将亚洲血统数据(21731 例病例;47444 例对照)纳入欧洲血统训练数据集(78473 例病例;107143 例对照)来扩展 CRC 的 PRS 开发。PRS 的 AUC 估计值(95%CI)分别为 0.63(0.62-0.64)、0.59(0.57-0.61)、0.62(0.60-0.63)和 0.65(0.63-0.66),在包括亚洲、黑/非裔美国人、拉丁裔/西班牙裔和非西班牙裔白人的 1681-3651 例病例和 8696-115105 例对照的独立数据集。它们在所有四个主要的美国种族和族裔群体中均显著优于以欧洲为中心的 PRS(p 值<0.05)。需要进一步纳入非欧洲血统人群,特别是黑/非裔美国人和拉丁裔/西班牙裔,以改善风险预测并在临床实践中应用 PRS 时提高公平性。